P8IP
LGND icon

Pier 88 Investment Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Pier 88 Investment Partners’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$822K Sell
2,600
-5,400
-68% -$1.27M 0.2% 38
2026
Q1 		$1.6M Sell
8,000
-520
-6% -$103K 0.41% 33
2025
Q4 		$1.61M Buy
8,520
+1,320
+18% +$254K 0.36% 39
2025
Q3 		$1.28M Buy
+7,200
New +$1.07M 0.24% 44

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pier 88 Investment Partners's LGND Position: Q2 2026 in Review

Pier 88 Investment Partners reduced its Ligand Pharmaceuticals (LGND) stake by 68% in Q2 2026, selling an estimated $1.27M and leaving 2,600 shares worth $822K. The position accounts for 0.2% of the portfolio, ranked #38.

Pier 88 Investment Partners first reported a position in LGND in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.61M in Q4 2025. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Pier 88 Investment Partners held 2,600 shares of Ligand Pharmaceuticals worth $822K as of Q2 2026.
  • Pier 88 Investment Partners sold 5,400 Ligand Pharmaceuticals shares in Q2 2026, an estimated $1.27M.
  • Ligand Pharmaceuticals made up 0.2% of Pier 88 Investment Partners's portfolio in Q2 2026, its #38 holding.
  • Pier 88 Investment Partners first reported a position in Ligand Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Pier 88 Investment Partners's Ligand Pharmaceuticals position peaked at $1.61M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Pier 88 Investment Partners's 13F filing for Q2 2026, filed 4 Aug 2026.